RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Newsroom

Anthony Hickey awarded Thomas T. Mercer Joint Prize from the American Association for Aerosol Research and International Society for Aerosols in Medicine

Anthony Hickey, Ph.D., an expert in aerosol and nanomaterials engineering at RTI International, received the Thomas T. Mercer Joint Prize from the American Association for Aerosol Research and International Society for Aerosols in Medicine.

The award recognizes Hickey for his achievements and groundbreaking research in the field of inhalable materials and pharmaceutical aerosols, including drugs and vaccines delivered by inhalers. His work has paved the way for new methods of treatment and prevention of asthma, cystic fibrosis, diabetes, tuberculosis and more.

The award honors the legacy of Thomas T. Mercer, a researcher and author whose research spanned aerosol physics and chemistry as well as inhalation toxicology, industrial hygiene and health physics.

Hickey has more than 30 years of academic and research experience in pulmonary biology, aerosol physics, powder dynamics, pharmacokinetics and drug disposition, formulation design and device development. He holds 22 patents and currently serves as a Distinguished Fellow at RTI and professor emeritus at the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill.